Searched for
FIRST GENERIC VERSION
India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...
India’s anti-obesity drug market sees slower growth after initial surge in generic semaglutide salesIndia's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...
Not all startups are built the same. Which category defines yours?Startup award categories are often shaped more by founder journeys, business models, and growth approaches than by sectors alone. Through r...
Dr Reddy’s launches generic Semaglutide injection, popular weight-loss drug, in CanadaDr Reddy's Laboratories has launched its generic Semaglutide injection in Canada. This marks a significant step for the company in providin...
Alembic Pharma gets USFDA tentative nod for generic prostate cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic version of Darolutamide tablets, targeting prostate c...
“AI Is not a fortune teller”: Rahul Ghose on the limits of algorithmic investingSynopsis - With AI increasingly entering the investing space, Rahul Ghose discusses how platforms like Hedged.in are using technology to im...
Cipla Q4 Results: Profit falls 55% YoY to Rs 555 crore; co declares Rs 13/sh dividendCipla Ltd announced a significant 55% year-on-year drop in its consolidated net profit for the fourth quarter, reaching Rs 555 crore. This ...
Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
Semaglutide race: Torrent grabs 38% market shareOver a dozen Indian companies have launched generic versions of the GLP1 drug used for diabetes and weight management since the expiry of N...
Outlook login not working? What caused Microsoft Outlook outage today — and was it Hacked?Is Outlook Down Right Now? Outlook login not working? What caused the Microsoft Outlook outage today — and was it hacked? Microsoft stayed ...
Cipla gets USFDA nod for generic respiratory issues treatment inhalation aerosolPharma major Cipla has secured final approval from the US health regulator for its generic albuterol sulfate inhalation aerosol. This marks...
AI-armed founders disrupting venture capitalism?Indian venture capitalists hold billions, but the traditional funding model faces disruption. Founders now build and scale businesses with ...
Dr Reddy's gets nod to roll out generic oral semaglutide drug"The formulation was clinically evaluated in a head-to-head comparative study conducted in India, which established the non-inferiority to ...
Novo Nordisk’s weight-loss drug patent loss sparks a ‘gold rush’ for generic drugmakersIndia's weight-loss drug market is seeing a major shift. Generic versions of Novo Nordisk's semaglutide are now available at lower prices. ...
Emcure slashes prices of weight management drug Poviztra by up to 55%Emcure Pharmaceuticals is making its weight management drug Poviztra more accessible. The price of the semaglutide injection will be cut by...
Natco Pharma soars 17% as path to launch Revlimid generic clearsNatco Pharma would be the first company to launch Revlimid (lenalidomide) in March 2022 as Dr Reddy’s settlement clears the path for the co...
Glenmark launches generic version of Zetia in US market"We have launched ezetimibe, the first and only generic version of Zetia (Merck) in the United States for the treatment of high cholesterol...
Indian companies in FDA's first list for generic Aciphex tabletsIndian firms including Dr Reddy's, Lupin and Torrent Pharma have received nod from the US health regulator to market the first generic vers...
- US govt okays generic versions of insomnia drug
The first generic versions of the insomnia drug Ambien have won US government approval.
- US court rejects Novartis bid to sell Zocor generics
The path was cleared for generic versions of Merck’s blockbuster Zocor cholesterol drug on Friday, after a US federal judge rejected a last...